My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Immuneering Corporation - Class A Common Stock (NQ:IMRX)

5.000 -0.250 (-4.76%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Immuneering Corporation - Class A Common Stock

< Previous 1 2 3 4 5 Next >

3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave ↗

February 14, 2024

Explore hidden-gem biotech stocks set for growth in a booming market. Uncover top picks ready to redefine healthcare innovation.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 21, 2023

Via Benzinga

4 Analysts Have This to Say About Immuneering ↗

August 08, 2023

Via Benzinga

Expert Ratings for Immuneering ↗

June 26, 2023

Via Benzinga

Analyst Doubles Immuneering Price Target Citing Initial Data Validation ↗

April 19, 2023

Via Benzinga

What 7 Analyst Ratings Have To Say About Immuneering ↗

April 19, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 07, 2023

Via Benzinga

Why Shares of Immuneering Jumped This Week ↗

March 24, 2023

Immuneering is ready to share information regarding its lead therapy.

Via The Motley Fool

Looking Into Immuneering's Return On Capital Employed ↗

March 09, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2023 ↗

April 19, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 06, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023 ↗

March 30, 2023

Via Benzinga

Top 5 Health Care Stocks That Are Ticking Portfolio Bombs ↗

March 14, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 08, 2023

Via Benzinga

Immuneering Earnings Preview ↗

March 03, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023 ↗

February 03, 2023

Via Benzinga

Immuneering's Return On Capital Employed Insights ↗

December 20, 2022

Via Benzinga

Why This Small-Cap Stock Is Gaining More Than 10% Today? ↗

July 08, 2022

Via Benzinga

Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday ↗

October 03, 2022

Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.

Via Benzinga

Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session ↗

September 30, 2022

Gainers

Via Benzinga

Micron, Charles River Laboratories And Some Other Big Stocks Moving Higher On Friday ↗

September 30, 2022

U.S. stocks traded slightly higher, with the Nasdaq Composite gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday ↗

September 23, 2022

Gainers

Via Benzinga

Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday ↗

September 14, 2022

Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 06, 2022

Gainers Metacrine (NASDAQ:MTCR) shares rose 13.8% to $0.54 during Tuesday's after-market session. This security traded at a volume of 3.0 million shares come close, making up 948.6% of its average...

Via Benzinga

Recap Of Friday's Biotech Catalysts - End Of the Day Summary ↗

September 02, 2022

Via Benzinga

Immuneering Shares Climb After Pursuing FDA Nod For RAS Mutant Tumor Study ↗

September 02, 2022

Immuneering (NASDAQ: IMRX) submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for its product candidate IMM-1-104 in development for the treatment of...

Via Benzinga

Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday ↗

September 02, 2022

Gainers

Via Benzinga

Tesla, Twitter And 76 Biggest Movers From Friday ↗

July 11, 2022

Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022 ↗

July 08, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 24, 2022

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.